Basic principles of the virulence of Cryptococcus

References

• Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13.
   PubMed Web of Science ®Google Scholar
• Drgona L, Khachatryan A, Stephens J, et al. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis. 2014;33:7–21.
   PubMed Web of Science ®Google Scholar
• Menzin J, Meyers JL, Friedman M, et al. The economic costs to United States hospitals of invasive fungal infections in transplant patients. Am J Infect Control. 2011;39:e15–20.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Perfect JR. Cryptococcus neoformans. Washington DC: ASM Press; 1998.
   Google Scholar
• Heitman J, Kozel TR, Kwon-Chung KJ, et al. Cryptococcus. From human pathogen to model yeast. Washington (DC): ASM Press; 2011.
   Google Scholar
• Park BI, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525–530.
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17:873–881.
   PubMed Web of Science ®Google Scholar
• Martin TR, Frevert CW Innate immunity in the lungs. Proc Am Thoracic Soc 2005; 2:403–411.
   PubMedGoogle Scholar
• Casadevall A, Steenbergen JN, Nosanchuk JD. ‘Ready made‘ virulence and ‘dual use‘ virulence factors in pathogenic environmental fungi–the Cryptococcus neoformans paradigm. Curr Opin Microbiol. 2003;6:332–337.
   PubMed Web of Science ®Google Scholar
• Littman ML, Borok R. Relation of the pigeon to cryptococcosis: natural carrier state, heat resistance and survival of Cryptococcus neoformans. Mycopathol Mycol Appl. 1968;35:329–345.
   PubMedGoogle Scholar
• Neilson JB, Ivey MH, Bulmer GS. Cryptococcus neoformans: pseudohyphal forms surviving culture with acanthamoeba polyphaga. Infect Immun. 1978;20:262–266.
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A. 2001;98:15245–15250.
   PubMed Web of Science ®Google Scholar
• Apidianakis Y, Rahme LG, Heitman J, et al. Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell. 2004;3:413–419.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun. 2005;73:3842–3850.
   PubMed Web of Science ®Google Scholar
• Warpeha KM, Park YD, Williamson PR. Susceptibility of intact germinating Arabidopsis thaliana to human fungal pathogens Cryptococcus neoformans and C. gattii. Appl Environ Microbiol. 2013;79:2979–2988.
   PubMed Web of Science ®Google Scholar
• Venn-Watson S, Daniels R, Smith C. Thirty year retrospective evaluation of pneumonia in a bottlenose dolphin Tursiops truncatus population. Dis Aquat Organ. 2012;99:237–242.
   PubMed Web of Science ®Google Scholar
• Malik R, Martin P, Wigney DI, et al. Nasopharyngeal cryptococcosis. Aust Vet J. 1997;75:483–488.
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Casadevall A. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 2003;5:667–675.
   PubMed Web of Science ®Google Scholar
• Casadevall A. Amoeba provide insight into the origin of virulence in pathogenic fungi. Adv Exp Med Biol. 2012;710:1–10.
   PubMed Web of Science ®Google Scholar
• Velagapudi R, Hsueh YP, Geunes-Boyer S, et al. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun. 2009;77:4345–4355.
   PubMed Web of Science ®Google Scholar
• Giles SS, Dagenais TR, Botts MR, et al. Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans. Infect Immun. 2009;77:3491–3500.
   PubMed Web of Science ®Google Scholar
• Botts MR, Hull CM. Dueling in the lung: how Cryptococcus spores race the host for survival. Curr Opin Microbiol. 2010;13:437–442.
   PubMed Web of Science ®Google Scholar
• Esher SK, Zaragoza O, Alspaugh JA. Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain. Mem Inst Oswaldo Cruz. 2018;113:e180057.
   PubMed Web of Science ®Google Scholar
• Kronstad J, Saikia S, Nielson ED, et al. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot Cell. 2012;11:109–118.
   PubMedGoogle Scholar
• Kozubowski L, Lee SC, Heitman J. Signalling pathways in the pathogenesis of Cryptococcus. Cell Microbiol. 2009;11:370–380.
   PubMed Web of Science ®Google Scholar
• Robert VA, Casadevall A. Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis. 2009;200:1623–1626.
   PubMed Web of Science ®Google Scholar
• Bergman A, Casadevall A. Mammalian endothermy optimally restricts fungi and metabolic costs. MBio. 2010;1:e00212–10.
   PubMed Web of Science ®Google Scholar
• Petzold EW, Himmelreich U, Mylonakis E, et al. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect Immun. 2006;74:5877–5887.
   PubMed Web of Science ®Google Scholar
• Giles SS, Batinic-Haberle I, Perfect JR, et al. Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth. Eukaryot Cell. 2005;4:46–54.
   PubMedGoogle Scholar
• Kraus PR, Fox DS, Cox GM, et al. The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol Microbiol. 2003;48:1377–1387.
   PubMed Web of Science ®Google Scholar
• Alspaugh JA, Cavallo LM, Perfect JR, et al. RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol. 2000;36:352–365.
   PubMed Web of Science ®Google Scholar
• Gerwien F, Skrahina V, Kasper L, et al. Metals in fungal virulence. FEMS Microbiol Rev. 2018;42:1–21. doi:ARTN fux050.
   Web of Science ®Google Scholar
• Kronstad JW, Hu G, Jung WH. An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans. Trends Microbiol. 2013;21:457–465.
   PubMed Web of Science ®Google Scholar
• Bairwa G, Hee Jung W, Kronstad JW. Iron acquisition in fungal pathogens of humans. Metallomics. 2017;9:215–227.
   PubMed Web of Science ®Google Scholar
• Saikia S, Oliveira D, Hu G, et al. Role of ferric reductases in iron acquisition and virulence in the fungal pathogen Cryptococcus neoformans. Infect Immun. 2014;82:839–850.
   PubMed Web of Science ®Google Scholar
• Cadieux B, Lian T, Hu G, et al. The mannoprotein cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans. J Infect Dis. 2013;207:1339–1347.
   PubMed Web of Science ®Google Scholar
• Selvig K, Alspaugh JA. pH response pathways in fungi: adapting to host-derived and environmental signals. Mycobiology. 2011;39:249–256.
   PubMedGoogle Scholar
• Ost KS, O‘Meara TR, Huda N, et al. The Cryptococcus neoformans alkaline response pathway: identification of a novel rim pathway activator. PLoS Genet. 2015;11:e1005159.
   PubMed Web of Science ®Google Scholar
• O‘Meara TR, Holmer SM, Selvig K, et al. Cryptococcus neoformans rim101 is associated with cell wall remodeling and evasion of the host immune responses. MBio. 2013;4:e00522–12.
   PubMed Web of Science ®Google Scholar
• O‘Meara TR, Norton D, Price MS, et al. Interaction of Cryptococcus neoformans rim101 and protein kinase A regulates capsule. PLoS Pathog. 2010;6:e1000776.
   PubMed Web of Science ®Google Scholar
• Ost KS, Esher SK, Leopold Wager CM, et al. Rim pathway-mediated alterations in the fungal cell wall influence immune recognition and inflammation. MBio. 2017;8:e02290–16.
   PubMed Web of Science ®Google Scholar
• Missall TA, Cherry-Harris JF, Lodge JK. Two glutathione peroxidases in the fungal pathogen Cryptococcus neoformans are expressed in the presence of specific substrates. Microbiology. 2005;151:2573–2581.
   PubMed Web of Science ®Google Scholar
• Missall TA, Lodge JK. Function of the thioredoxin proteins in Cryptococcus neoformans during stress or virulence and regulation by putative transcriptional modulators. Mol Microbiol. 2005;57:847–858.
   PubMed Web of Science ®Google Scholar
• Missall TA, Moran JM, Corbett JA, et al. Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1. Eukaryot Cell. 2005;4:202–208.
   PubMedGoogle Scholar
• Chaturvedi V, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neutrophils. evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol. 1996;156:3836–3840.
   PubMed Web of Science ®Google Scholar
• Brown SM, Upadhya R, Shoemaker JD, et al. Isocitrate dehydrogenase is important for nitrosative stress resistance in Cryptococcus neoformans, but oxidative stress resistance is not dependent on glucose-6-phosphate dehydrogenase. Eukaryot Cell. 2010;9:971–980.
   PubMedGoogle Scholar
• Chow ED, Liu OW, O‘Brien S, et al. Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature. Curr Genet. 2007;52:137–148.
   PubMed Web of Science ®Google Scholar
• de Jesus-Berrios M, Liu L, Nussbaum JC, et al. Enzymes that counteract nitrosative stress promote fungal virulence. Curr Biol. 2003;13:1963–1968.
   PubMed Web of Science ®Google Scholar
• Pirofski LA, Casadevall A. What is infectiveness and how is it involved in infection and immunity? BMC Immunol. 2015;16:13.
   PubMed Web of Science ®Google Scholar
• Schaller M, Borelli C, Korting HC, et al. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48:365–377.
   PubMed Web of Science ®Google Scholar
• Singh G, Singh G, Jadeja D, et al. Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system. Crit Rev Microbiol. 2010;36:259–269.
   PubMed Web of Science ®Google Scholar
• Toth R, Toth A, Vagvolgyi C, et al. Candida parapsilosis secreted lipase as an important virulence factor. Curr Protein Pept Sci. 2017;18:1043–1049.
   PubMed Web of Science ®Google Scholar
• Zimmer BL, Roberts GD. Rapid selective urease test for presumptive identification of Cryptococcus neoformans. J Clin Microbiol. 1979;10:380–381.
   PubMed Web of Science ®Google Scholar
• Fu MS, Coelho C, De Leon-Rodriguez CM, et al. Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH. PLoS Pathog. 2018;14:e1007144.
   PubMed Web of Science ®Google Scholar
• Cox GM, Mukherjee J, Cole GT, et al. Urease as a virulence factor in experimental cryptococcosis. Infect Immun. 2000;68:443–448.
   PubMed Web of Science ®Google Scholar
• Olszewski MA, Noverr MC, Chen GH, et al. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol. 2004;164:1761–1771.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Jackson N, Buckley C. Helicobacter pylori, ammonia and the brain. Gut. 1997;40:805–806.
   PubMed Web of Science ®Google Scholar
• Singh A, Panting RJ, Varma A, et al. Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans. MBio. 2013;4:e00220–13.
   PubMed Web of Science ®Google Scholar
• Cherniak R, Jones RG, Reiss E. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr Res. 1988;172:113–138.
   PubMed Web of Science ®Google Scholar
• Murphy JW, Mosley RL, Cherniak R, et al. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun. 1988;56:424–431.
   PubMed Web of Science ®Google Scholar
• Cherniak R, Reiss E, Turner S. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr Res. 1982;103:239–250.
   Web of Science ®Google Scholar
• Heiss C, Klutts JS, Wang Z, et al. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Carbohydr Res. 2009;344:915–920.
   PubMed Web of Science ®Google Scholar
• Murphy JW. Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis. 1988;10(Suppl 2):S432–5.
   PubMedGoogle Scholar
• Vartivarian SE, Reyes GH, Jacobson ES, et al. Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol. 1989;171:6850–6852.
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Alvarez M, Fonseca FL, et al. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell. 2008;7:602–609.
   PubMedGoogle Scholar
• Pierini LM, Doering TL. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol Microbiol. 2001;41:105–115.
   PubMed Web of Science ®Google Scholar
• Frases S, Pontes B, Nimrichter L, et al. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc Natl Acad Sci U S A. 2009;106:1228–1233.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Rodrigues ML, De Jesus M, et al. The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol. 2009;68:133–216.
   PubMed Web of Science ®Google Scholar
• O‘Meara TR, Alspaugh JA. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev. 2012;25:387–408.
   PubMed Web of Science ®Google Scholar
• Doering TL. How does Cryptococcus get its coat? Trends Microbiol. 2000;8:547–553.
   PubMed Web of Science ®Google Scholar
• Doering TL. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol. 2009;63:223–247.
   PubMed Web of Science ®Google Scholar
• Wang ZA, Li LX, Doering TL. Unraveling synthesis of the cryptococcal cell wall and capsule. Glycobiology. 2018;28:719–730.
   PubMed Web of Science ®Google Scholar
• Ding H, Mayer FL, Sanchez-Leon E, et al. Networks of fibers and factors: regulation of capsule formation in Cryptococcus neoformans. F1000Res. 2016;5.
   Google Scholar
• Agustinho DP, Miller LC, Li LX, et al. Peeling the onion: the outer layers of Cryptococcus neoformans. Mem Inst Oswaldo Cruz. 2018;113:e180040.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Coelho C, Cordero RJB, et al. The capsule of Cryptococcus neoformans. Virulence. 2018;1–10.
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Casadevall A, Zaragoza O. The architecture and antigenic composition of the polysaccharide capsule. In: Heitman J, Kozel TR, Kwon-Chung KJ, et al., editors. Cryptococcus from human pathogen to model yeast. Washington (D.C): ASM Press; 2011. p. 43–54.
   Google Scholar
• Rodrigues ML, Nimrichter L, Oliveira DL, et al. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell. 2007;6:48–59.
   PubMed Web of Science ®Google Scholar
• Nimrichter L, de Souza MM, Del Poeta M, et al. Extracellular vesicle-associated transitory cell wall components and their impact on the interaction of fungi with host cells. Front Microbiol. 2016;7:1034.
   PubMed Web of Science ®Google Scholar
• Oliveira DL, Freire-de-Lima CG, Nosanchuk JD, et al. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infect Immun. 2010;78:1601–1609.
   PubMed Web of Science ®Google Scholar
• Chang YC, Kwon-Chung KJ. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol. 1994;14:4912–4919.
   PubMed Web of Science ®Google Scholar
• Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol. 1982;129:1675–1680.
   PubMed Web of Science ®Google Scholar
• Kozel TR, Mastroianni RP. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun. 1976;14:62–67.
   PubMed Web of Science ®Google Scholar
• Aksenov SI, Babyeva IP, Golubev VI. On the mechanism of adaptation of micro-organisms to conditions of extreme low humidity. Life Sci Space Res. 1973;11:55–61.
   PubMedGoogle Scholar
• Zaragoza O, Chrisman CJ, Castelli MV, et al. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol. 2008;10:2043–2057.
   PubMed Web of Science ®Google Scholar
• Cordero RJ, Frases S, Guimaraes AJ, et al. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol. 2011;79:1101–1117.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Pericolini E, Gabrielli E, et al. Elucidating the immunological function of the Cryptococcus neoformans capsule. Future Microbiol. 2013;8:1107–1116.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol. 2000;38:407–417.
   PubMed Web of Science ®Google Scholar
• Dong ZM, Murphy JW. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun. 1993;61:5067–5077.
   PubMed Web of Science ®Google Scholar
• Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest. 1996;97:689–698.
   PubMed Web of Science ®Google Scholar
• Ellerbroek PM, Hoepelman AI, Wolbers F, et al. Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells. Infect Immun. 2002;70:4762–4771.
   PubMed Web of Science ®Google Scholar
• Ellerbroek PM, Ulfman LH, Hoepelman AI, et al. Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium. Cell Microbiol. 2004;6:581–592.
   PubMed Web of Science ®Google Scholar
• Dong ZM, Murphy JW. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun. 1997;65:557–563.
   PubMed Web of Science ®Google Scholar
• Blackstock R, Hall NK. Non-specific immunosuppression by Cryptococcus neoformans infection. Mycopathologia. 1984;86:35–43.
   PubMed Web of Science ®Google Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972;5:896–901.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Pericolini E, Gabrielli E, et al. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Immunotherapy. 2011;3:997–1005.
   PubMed Web of Science ®Google Scholar
• Blackstock R. Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF. J Med Vet Mycol. 1996;34:19–30.
   PubMedGoogle Scholar
• Blackstock R, Casadevall A. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival. Immunology. 1997;92:334–339.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A. The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies. Curr Mol Med. 2005;5:413–420.
   PubMed Web of Science ®Google Scholar
• Chiapello LS, Baronetti JL, Aoki MP, et al. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology. 2004;113:392–400.
   PubMed Web of Science ®Google Scholar
• De Jesus M, Nicola AM, Frases S, et al. Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage. J Immunol. 2009;183:3885–3894.
   PubMed Web of Science ®Google Scholar
• Chiapello LS, Baronetti JL, Garro AP, et al. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immunol. 2008;20:1527–1541.
   PubMed Web of Science ®Google Scholar
• Monari C, Pericolini E, Bistoni G, et al. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. J Immunol. 2005;174:3461–3468.
   PubMed Web of Science ®Google Scholar
• Villena SN, Pinheiro RO, Pinheiro CS, et al. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol. 2008;10:1274–1285.
   PubMed Web of Science ®Google Scholar
• Geunes-Boyer S, Beers MF, Perfect JR, et al. Surfactant protein D facilitates Cryptococcus neoformans infection. Infect Immun. 2012;80:2444–2453.
   PubMed Web of Science ®Google Scholar
• Holmer SM, Evans KS, Asfaw YG, et al. Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis. Infect Immun. 2014;82:683–693.
   PubMed Web of Science ®Google Scholar
• Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J Clin Microbiol. 1978;7:146–152.
   PubMed Web of Science ®Google Scholar
• Nurudeen TA, Ahearn DG. Regulation of melanin production by Cryptococcus neoformans. J Clin Microbiol. 1979;10:724–729.
   PubMed Web of Science ®Google Scholar
• Pukkila-Worley R, Gerrald QD, Kraus PR, et al. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell. 2005;4:190–201.
   PubMedGoogle Scholar
• Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982;150:1414–1421.
   PubMed Web of Science ®Google Scholar
• Salas SD, Bennett JE, Kwon-Chung KJ, et al. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med. 1996;184:377–386.
   PubMed Web of Science ®Google Scholar
• Rosas AL, Casadevall A. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol Lett. 1997;153:265–272.
   PubMed Web of Science ®Google Scholar
• Wang Y, Casadevall A. Decreased susceptibility of melanized Cryptococcus neoformans to UV light. Appl Environ Microbiol. 1994;60:3864–3866.
   PubMed Web of Science ®Google Scholar
• Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother. 2006;50:3519–3528.
   PubMed Web of Science ®Google Scholar
• Wang Y, Casadevall A. Growth of Cryptococcus neoformans in presence of L-Dopa decreases its susceptibility to amphotericin B. Antimicrob Agents Chemother. 1994;38:2648–2650.
   PubMed Web of Science ®Google Scholar
• van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother. 2002;46:3394–3400.
   PubMed Web of Science ®Google Scholar
• Cordero RJB, Robert V, Cardinali G, et al. Impact of yeast pigmentation on heat capture and latitudinal distribution. Curr Biol. 2018;28:2657–64 e3.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Williamson PR, Fajardo RS, et al. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun. 2004;72:1693–1699.
   PubMed Web of Science ®Google Scholar
• Mednick AJ, Nosanchuk JD, Casadevall A. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun. 2005;73:2012–2019.
   PubMed Web of Science ®Google Scholar
• Liu L, Tewari RP, Williamson PR. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect Immun. 1999;67:6034–6039.
   PubMed Web of Science ®Google Scholar
• Rosas AL, MacGill RS, Nosanchuk JD, et al. Activation of the alternative complement pathway by fungal melanins. Clin Diagn Lab Immunol. 2002;9:144–148.
   PubMedGoogle Scholar
• Diamond RD, Bennett JE. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun. 1973;7:231–236.
   PubMed Web of Science ®Google Scholar
• Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A. 2002;99:3165–3170.
   PubMed Web of Science ®Google Scholar
• Smith LM, Dixon EF, May RC. The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation. Cell Microbiol. 2015;17:702–713.
   PubMed Web of Science ®Google Scholar
• De Leon-Rodriguez CM, Rossi DCP, Fu MS, et al. The outcome of the Cryptococcus neoformans-macrophage interaction depends on phagolysosomal membrane integrity. J Immunol. 2018;201:583–603.
   PubMed Web of Science ®Google Scholar
• Ma H, Croudace JE, Lammas DA, et al. Expulsion of live pathogenic yeast by macrophages. Curr Biol. 2006;16:2156–2160.
   PubMed Web of Science ®Google Scholar
• Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol. 2006;16:2161–2165.
   PubMed Web of Science ®Google Scholar
• Alvarez M, Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 2007;8:16.
   PubMed Web of Science ®Google Scholar
• Ma H, Croudace JE, Lammas DA, et al. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol. 2007;8:15.
   PubMed Web of Science ®Google Scholar
• McFadden D, Zaragoza O, Casadevall A. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 2006;14:497–505.
   PubMed Web of Science ®Google Scholar
• Zaragoza O. Multiple disguises for the same party: the concepts of morphogenesis and phenotypic variations in Cryptococcus neoformans. Front Microbiol. 2011;2:181.
   PubMed Web of Science ®Google Scholar
• Vartivarian SE, Anaissie EJ, Cowart RE, et al. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis. 1993;167:186–190.
   PubMed Web of Science ®Google Scholar
• Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. regulation of capsule synthesis by carbon dioxide. J Clin Invest. 1985;76:508–516.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Fries BC, Casadevall A. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun. 2003;71:6155–6164.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Casadevall A. Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online. 2004;6:10–15.
   PubMedGoogle Scholar
• Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology. 2001;147:2355–2365.
   PubMed Web of Science ®Google Scholar
• Chrisman CJ, Albuquerque P, Guimaraes AJ, et al. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog. 2011;7:e1002047.
   PubMed Web of Science ®Google Scholar
• Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, et al. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One. 2011;6:e24485.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Taborda CP, Casadevall A. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Euro J Immnunol. 2003;33:1957–1967.
   PubMed Web of Science ®Google Scholar
• Robertson EJ, Najjuka G, Rolfes MA, et al. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. J Infect Dis. 2014;209:74–82.
   PubMed Web of Science ®Google Scholar
• McFadden DC, Fries BC, Wang F, et al. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell. 2007;6:1464–1473.
   PubMed Web of Science ®Google Scholar
• Charlier C, Chretien F, Baudrimont M, et al. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol. 2005;166:421–432.
   PubMed Web of Science ®Google Scholar
• Gates MA, Thorkildson P, Kozel TR. Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol. 2004;52:13–24.
   PubMed Web of Science ®Google Scholar
• Maxson ME, Dadachova E, Casadevall A, et al. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell. 2007;6:95–109.
   PubMedGoogle Scholar
• Romani L, Bistoni F, Puccetti P. Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol. 2003;6:338–343.
   PubMed Web of Science ®Google Scholar
• San-Blas G, Travassos LR, Fries BC, et al. Fungal morphogenesis and virulence. Med Mycol. 2000;38(Suppl 1):79–86.
   PubMedGoogle Scholar
• Trevijano-Contador N, Rueda C, Zaragoza O. Fungal morphogenetic changes inside the mammalian host. Semin Cell Dev Biol. 2016;57:100–109.
   PubMed Web of Science ®Google Scholar
• Lee SC, Phadke S, Sun S, et al. Pseudohyphal growth of Cryptococcus neoformans is a reversible dimorphic transition in response to ammonium that requires Amt1 and Amt2 ammonium permeases. Eukaryot Cell. 2012;11:1391–1398.
   PubMedGoogle Scholar
• Lin J, Idnurm A, Lin X. Morphology and its underlying genetic regulation impact the interaction between Cryptococcus neoformans and its hosts. Med Mycol. 2015;53:493–504.
   PubMed Web of Science ®Google Scholar
• Okagaki LH, Strain AK, Nielsen JN, et al. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog. 2010;6:e1000953.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Garcia-Rodas R, Nosanchuk JD, et al. Fungal cell gigantism during mammalian infection. PLoS Pathog. 2010;6:e1000945.
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Nielsen K. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol. 2013;16:409–413.
   PubMed Web of Science ®Google Scholar
• Okagaki LH, Nielsen K. Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell. 2012;11:820–826.
   PubMedGoogle Scholar
• Gerstein AC, Fu MS, Mukaremera L, et al. Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation. MBio. 2015;6:e01340–15.
   PubMed Web of Science ®Google Scholar
• Crabtree JN, Okagaki LH, Wiesner DL, et al. Titan cell production enhances the virulence of Cryptococcus neoformans. Infect Immun. 2012;80:3776–3785.
   PubMed Web of Science ®Google Scholar
• Garcia-Barbazan I, Trevijano-Contador N, Rueda C, et al. The formation of titan cells in Cryptococcus neoformans depends on the mouse strain and correlates with induction of Th2-type responses. Cell Microbiol. 2016;18:111–124.
   PubMed Web of Science ®Google Scholar
• Hommel B, Mukaremera L, Cordero RJB, et al. Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators. PLoS Pathog. 2018;14:e1006982.
   PubMed Web of Science ®Google Scholar
• Trevijano-Contador N, de Oliveira HC, Garcia-Rodas R, et al. Cryptococcus neoformans can form titan-like cells in vitro in response to multiple signals. PLoS Pathog. 2018;14:e1007007.
   PubMed Web of Science ®Google Scholar
• Dambuza IM, Drake T, Chapuis A, et al. The Cryptococcus neoformans titan cell is an inducible and regulated morphotype underlying pathogenesis. PLoS Pathog. 2018;14:e1006978.
   PubMed Web of Science ®Google Scholar
• Homer CM, Summers DK, Goranov AI, et al. Intracellular action of a secreted peptide required for fungal virulence. Cell Host Microbe. 2016;19:849–864.
   PubMed Web of Science ®Google Scholar
• Lee H, Chang YC, Nardone G, et al. TUP1 disruption in Cryptococcus neoformans uncovers a peptide-mediated density-dependent growth phenomenon that mimics quorum sensing. Mol Microbiol. 2007;64:591–601.
   PubMed Web of Science ®Google Scholar
• Okagaki LH, Wang Y, Ballou ER, et al. Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot Cell. 2011. Epub ahead of print
   PubMedGoogle Scholar
• Choi J, Vogl AW, Kronstad JW. Regulated expression of cyclic AMP-dependent protein kinase A reveals an influence on cell size and the secretion of virulence factors in Cryptococcus neoformans. Mol Microbiol. 2012;85:700–715.
   PubMed Web of Science ®Google Scholar
• Tseng HK, Huang TY, Wu AY, et al. How Cryptococcus interacts with the blood-brain barrier. Future Microbiol. 2015;10:1669–1682.
   PubMed Web of Science ®Google Scholar
• Colombo AC, Rodrigues ML. Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis. An Acad Bras Cienc. 2015;87:1293–1309.
   PubMed Web of Science ®Google Scholar
• Chen SH, Stins MF, Huang SH, et al. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol. 2003;52:961–970.
   PubMed Web of Science ®Google Scholar
• Shi M, Colarusso P, Mody CH. Real-time in vivo imaging of fungal migration to the central nervous system. Cell Microbiol. 2012;14:1819–1827.
   PubMed Web of Science ®Google Scholar
• Jong A, Wu CH, Shackleford GM, et al. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol. 2008;10:1313–1326.
   PubMed Web of Science ®Google Scholar
• Vu K, Eigenheer RA, Phinney BS, et al. Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells. Infect Immun. 2013;81:3139–3147.
   PubMed Web of Science ®Google Scholar
• Liu TB, Kim JC, Wang Y, et al. Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier. PLoS Pathog. 2013;9:e1003247.
   PubMed Web of Science ®Google Scholar
• Santangelo R, Zoellner H, Sorrell T, et al. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun. 2004;72:2229–2239.
   PubMed Web of Science ®Google Scholar
• Na Pombejra S, Salemi M, Phinney BS, et al. The metalloprotease, Mpr1, engages annexinA2 to promote the transcytosis of fungal cells across the blood-brain barrier. Front Cell Infect Microbiol. 2017;7:296.
   PubMed Web of Science ®Google Scholar
• Charlier C, Nielsen K, Daou S, et al. Evidence for a role of monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 2009;77:120–127.
   PubMed Web of Science ®Google Scholar
• Sorrell TC, Juillard PG, Djordjevic JT, et al. Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265. Microbes Infect. 2016;18:57–67.
   PubMed Web of Science ®Google Scholar
• Santiago-Tirado FH, Onken MD, Cooper JA, et al. Trojan horse transit contributes to blood-brain barrier crossing of a eukaryotic pathogen. MBio. 2017;8:e02183–16.
   PubMed Web of Science ®Google Scholar